Live Quote · NASDAQAVLNHealthcare· Biotechnology

Avalyn Pharma Inc. Common Stock

$28.40▼ 1.05%($-0.30)
MKT CAP $1.26BNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
73
Valuation
20
Profitability
15
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVLN research report →

Analyst Price Target
$60.00+111.3% vs. today

Range $51 – $80

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-3.70% · this period
$39.25$31.29$23.33Apr 30Aug 12Nov 20
52-Week Range34% of range
Low
$22.24
Current
$28.40
High
$40.17